Investment
Features
FeesSafety
Academy
More
Pluang+

Unisys and Refroid partner to enhance AI infrastructure with liquid cooling and global support services

Market News
20 Aug 2026
PRNewsWire
View Source
Bullish
pluang ai news

Unisys and Refroid Technologies have formed a partnership to provide advanced liquid cooling solutions and global field services for AI infrastructure. This collaboration addresses the growing demand for efficient, high-performance computing environments needed to support energy-intensive AI workloads. By combining Refroid's cooling technologies with Unisys' deployment and maintenance expertise, organizations can improve AI infrastructure reliability and efficiency. The partnership aims to simplify AI infrastructure deployment and support worldwide, meeting the increasing global investment in AI technologies.

More News

Nearly 30% of Berkshire Hathaway's $356B portfolio is in two AI stocks, highlighting AI's growing investment appeal.

Nearly 30% of Berkshire Hathaway's $356B portfolio is in two AI stocks, highlighting AI's growing investment appeal.

Berkshire Hathaway has allocated 29.7% of its $356 billion investment portfolio to just two artificial intelligence stocks. This significant concentration underscores the growing confidence and interest in AI technologies as key drivers of future gro...

Market News
Bearish
1 hour ago
Happen Bank offers a top 4.00% APY high-yield savings account ideal for emergency funds in 2026.

Happen Bank offers a top 4.00% APY high-yield savings account ideal for emergency funds in 2026.

Happen Bank LevelUp Savings is recommended as the best high-yield savings account for emergency funds in 2026, offering a 4.00% APY with monthly deposits of $250 or more. It provides safety with FDIC insurance up to $250,000, no fees, easy ATM access...

Others
Bullish
4 hours ago
IceCure Medical's post-marketing study for ProSense® breast cancer cryoablation approved, patient enrollment to start soon.

IceCure Medical's post-marketing study for ProSense® breast cancer cryoablation approved, patient enrollment to start soon.

IceCure Medical received approval from the Institutional Review Board at West Cancer Center to start a post-marketing study called the ChoICE Study for its ProSense® cryoablation device, used in treating low-risk breast cancer in women aged 70 and ab...

Market News
Bullish
4 hours ago
Lumen Technologies posts mixed Q2 results with AI growth but overall revenue down 9.3% YoY

Lumen Technologies posts mixed Q2 results with AI growth but overall revenue down 9.3% YoY

Lumen Technologies reported Q2 2026 results that beat expectations on revenue and earnings per share, driven by a 14.1% year-over-year growth in AI and strategic services which now make up 53% of revenue. However, overall revenue declined 9.3% year-o...

Company Fundamentals
Neutral
4 hours ago
Federal Signal posts strong Q2 with 20% revenue growth, raises 2026 outlook, remains a Buy.

Federal Signal posts strong Q2 with 20% revenue growth, raises 2026 outlook, remains a Buy.

Federal Signal Corporation reported strong Q2 results with double-digit growth in earnings per share and revenue, driven largely by a 20% revenue increase in its Environmental Solutions segment due to favorable acquisitions. The company raised its fu...

Company Fundamentals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App